Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Status:
Active, not recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if Abraxane and Gemcitabine given together will
be effective in treating small cell cancer that has progressed after one line of treatment.